Skip links and keyboard navigation

From bed-bound to fun runs

5 October 2018

After spending almost eight months in Princess Alexandra Hospital’s (PAH) Brain Injury Rehabilitation Service, Troy Meteyard has returned home today and his final parting words to the team who helped him recover were an emotional thank you.

At the beginning of his rehab journey, Troy needed the help of two people to move.

But he was determined to regain his independence, and through hard work and perseverance his strength and coordination improved enough for him to not only walk but run independently.

“I had my accident on Christmas Eve 2017. I can remember New Year’s Day, and then nothing until waking up in February,” he said.

“I was transferred to the Jasmine Unit*, which is where I would call home for six months.

“I did more rehab there, progressing my walking and finally becoming Independent.

“I started a jogging routine with Nick [PAH Allied Health Assistant] and finally achieved a 5km park run goal in 30 minutes.

“I have come a long way but still have a long road ahead.”

Troy enjoyed an active lifestyle, was a keen cyclist, and played volleyball at a competitive level before his injury.

Now, his goal is to return to his previous fitness routine and gradually make his way back to playing volleyball again.

*The Jasmine Unit is part of PAH’s Brain Injury Rehabilitation Service and provides assessment and management for people who have sustained a severe acquired brain injury and require slow stream rehabilitation over a longer period.

Last updated 5 October 2018
Last reviewed 5 October 2018

Other news

2B bedside audit success satisfaction PI and falls

The key to safely managing high risk orthopaedic patients

Nursing staff in Orthopaedics Ward 2B are celebrating continued success in positive change management after receiving great results in the 2018 Queensland Bedside Audit (QBA).

Sandro Porceddu

Brisbane Researchers targeting 200 per cent increase in Human Papillomavirus head and neck cancers

Brisbane cancer researchers are advancing human trials to treat Human Papillomavirus (HPV) associated cancers of the head and neck using a novel therapy of combining a newly developed HPV vaccine with immunotherapy.